Associate Professor Danny Liew
Associate Professor
Consultant Pysician
| telephone | +61 3 9288 3640 |
| facsmilie | +61 3 9288 3652 |
| dliew @ medstv.unimelb.edu.au |
Profile
Danny Liew joined the Department of Medicine and St Vincent's Hospital in October 2007. His research interests lie in clinical trials, public health/epidemiology and health economics, especially in relation to the therapeutics of cardiovascular and metabolic diseases. Danny holds a National Heart Foundation Public Health Fellowship and is also a Consultant Physician at St Vincent's Hospital, where he leads the Clinical Pharmacology service.
Professional Activities:
Member, National Drugs and Poisons Schedule Committee; Co-opted member, Adverse Drug Reactions Advisory Committee; Member, Prescribing Practice Advisory Committee of the Nurses Board of Victoria; Member, Medication Management Advisory Group of the Victorian Department of Human Service; RACP Examiner and Lecturer; RACS Lecturer; Member of the following committees at St Vincent's Hospital Melbourne: Pharmacy Committee, Clinical Research Support Committee, Grand Rounds Committee, Documentation Committee.
Qualifications
BMedSc MBBS GradCertHealthEcon FRACP PhD
Major Grants
- Australian Research Council Linkage Project: COst-effectiveness analyses of improved adherence to Management PLans among AustralIANS (COMPLIANS). *Principal Investigator.
- Australian Research Council Linkage Project: 'Epidemiological Modelling of Cardiovascular Disease and Diabetes in Australia'. *Principal Investigator. 2007-2009
- National Health and Medical Research Council of Australia Project Grant: 'Risk and Determinants of Fatal and Non-fatal Coronary Heart Disease in the Melbourne Collaborative Cohort Study'. 2005-2009
- National Heart Foundation of Australia Grant-in-Aid: 'A Pilot for the Victorian Cohort Study (ViCS)'. 2004-2005
- National Heart Foundation of Australia Grant-in-Aid: 'The Assessment of Long-term Coronary Risk in the Australian Population'. 2002-2003
Selected Publications
- Magliano DJ, Shaw JE, Shortreed S, Nusselder WJ, Liew D, Barr ELM, Zimmet PZ, Peeters A. Lifetime risk and projected population prevalence of diabetes. Diabetologia [In press].
- Walls H, Peeters A, Reid C. Liew D, McNeil JJ. Predicting the effectiveness of prevention: a role for epidemiological modelling. J Primary Prev. 2008 Jun 25. [Epub ahead of print].
- Rogers SL, Magliano DJ, Levison DB, Webb K, Clarke PJ, Grobler MP, Liew D. A dose-specific meta-analysis of lipid changes in randomized controlled trials of atorvastatin versus simvastatin. Clin Ther. 2007; 29: 242-252.
- Haas SJ, Hill R, Krum H, Liew D, Tonkin A, Demos L, Stephan K, McNeil JJ. Clozapine-associated myocarditis - a review of 116 cases of supected myocarditis associated with the use of clozapine in Australia 1993-2003. Drug Saf 2007; 30: 47-57.
- Aw TJ, Liew D, Tofler G, Schneider H, Morel-Kopp MC, Krum H. Can the blood pressure effects of COX-2 selective inhibitors be explained by changes in pasma aldosterone levels? J Hypertens. 2006; 24: 1979-1984.
- Liew D, Lim SS, Bertram M, McNeil JJ, Vos T. A Model for Undertaking Effectiveness and Cost-Effectiveness Analyses of Primary Preventive Strategies in Cardiovascular Disease. Eur J Cardiovasc Prev Rehabil. 2006; 13: 515-522.
- Krum H, Aw TJ, Liew D, Haas S. Blood Pressure Effects of COX-2 Inhibitors. J Cardiovasc Pharmacol 2006; 47 Suppl 1: S43-S48.
- Nelson MR, Liew D, Bertram M, Vos T. Epidemiological modelling of routine use of low dose aspirin for the primary prevention of coronary heart disease and stroke in those aged >=70. BMJ. 2005; 330:1306. Epub 2005 May 20.
- Liew D, Krum H. The Cardiovascular Safety of Celecoxib. Future Cardiology 2005; 1: 709-722.
- Liew D, Schneider H, D’Agostino J, Shaw J, Krum H. Utility of B-Type Natriuretic Peptide (BNP) as a Screen for Left Ventricular Dysfunction in Patients With Diabetes. Diabetes Care. 2004; 27: 848.
- Krum H, Liew D. New and Emerging Drug Therapies for the Management of Acute Heart Failure. Intern Med J. 2003; 33: 515-520.
- Magliano D, Liew D, Sundararajan V, Ashton E, McNeil JJ. Novel risk factors for cardiovascular disease. J Cardiovasc Risk 2003; 10: 41-55.
- Liew D, McNeil JJ, Peeters A, Lim S, Vos T. Epidemiological Modelling (Including Economic Modelling) and its Role in Preventive Drug Therapy. Med J Aust 2002; 177: 364-367.